Celanese Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.5B | $10.3B | $10.9B | $9.7B | $8.5B |
| Cost of revenue | $7.6B | $7.9B | $8.3B | $7.3B | $5.9B |
| Gross profit | $2.0B | $2.3B | $2.6B | $2.4B | $2.7B |
| Selling, general & administrative | $899.0M | $1.0B | $1.1B | $824.0M | $633.0M |
| Research and development | $125.0M | $130.0M | $146.0M | $112.0M | $86.0M |
| Operating income | -$786.0M | -$720.0M | $1.7B | $1.4B | $1.9B |
| Interest expense | $701.0M | $676.0M | $720.0M | $405.0M | $91.0M |
| Pretax income | -$1.2B | -$1.0B | $1.2B | $1.4B | $2.2B |
| Income tax expense | -$90.0M | $507.0M | -$795.0M | -$489.0M | $330.0M |
| Net income | -$1.2B | -$1.5B | $1.9B | $1.9B | $1.9B |
| Balance Sheet | |||||
| Cash and equivalents | — | — | — | $1.5B | $536.0M |
| Current assets | $5.7B | $5.1B | $6.2B | $6.6B | $3.8B |
| Total assets | $21.7B | $22.8B | $26.6B | $26.3B | $12.0B |
| Current liabilities | $3.7B | $3.9B | $4.1B | $4.1B | $2.5B |
| Total debt | $12.7B | $12.6B | $13.8B | $14.8B | $4.0B |
| Stockholders' equity | $4.0B | $5.1B | $7.1B | $5.6B | $4.2B |
| Cash Flow Statement | |||||
| Cash from operations | $1.1B | $966.0M | $1.9B | $1.8B | $1.8B |
| Depreciation and amortization | $760.0M | $801.0M | $706.0M | $462.0M | $371.0M |
| Stock-based compensation | $24.0M | $32.0M | $40.0M | $60.0M | $95.0M |
| Capital expenditure | $343.0M | $435.0M | $568.0M | $543.0M | $467.0M |
| Free cash flow | $803.0M | $531.0M | $1.3B | $1.3B | $1.3B |
| Dividends paid | $13.0M | $307.0M | $305.0M | $297.0M | $304.0M |
| Share repurchases | — | $0 | $0 | $17.0M | $1.0B |
| Impairments | $1.5B | $1.6B | $15.0M | $14.0M | $2.0M |
Shares outstanding 109.7M · Free float 99.6%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.